Wendy Mcdermott serves as Executive at LEXICON PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Wendy Mcdermott has executed 7 insider transactions totaling $35.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 28, 2024 involved exercising options for 18,944 shares valued at $0.
Wendy Mcdermott currently holds 47,422 shares of LEXICON PHARMACEUTICALS, INC. (LXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendy Mcdermott has been a net buyer of LXRX stock. They have purchased $35.3K and sold $0 worth of shares.
Wendy Mcdermott's most recent insider trade was on Feb 28, 2024, when they sold 18,944 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 27,697 |
| $N/A |
| Discretionary |
| Feb 28, 2024 | LXRX | $58.8K | Payment | 22,425 | $2.62 | Discretionary |
| Aug 4, 2023 | LXRX | $11.0K | Purchase | 6,000 | $1.84 | Discretionary |
| Jun 23, 2023 | LXRX | $24.3K | Purchase | 10,000 | $2.43 | Discretionary |
| Feb 28, 2023 | LXRX | $14.0K | Payment | 6,465 | $2.17 | Discretionary |
| Feb 28, 2023 | LXRX | $0 | Option Exercise | 18,943 | $N/A | Discretionary |